|Application ||WB, FC, IHC-P, E|
|Other Accession||Q99PD4, Q9R0Q6, Q1JP79|
|Predicted||Bovine, Mouse, Rat|
|Calculated MW||41569 Da|
|Antigen Region||157-184 aa|
|Other Names||Actin-related protein 2/3 complex subunit 1A, SOP2-like protein, ARPC1A, SOP2L|
|Target/Specificity||This ARPC1A antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 157-184 amino acids from the Central region of human ARPC1A.|
|Format||Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is prepared by Saturated Ammonium Sulfate (SAS) precipitation followed by dialysis against PBS.|
|Storage||Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.|
|Precautions||ARPC1A Antibody (Center) is for research use only and not for use in diagnostic or therapeutic procedures.|
|Function||Probably functions as component of the Arp2/3 complex which is involved in regulation of actin polymerization and together with an activating nucleation-promoting factor (NPF) mediates the formation of branched actin networks.|
|Cellular Location||Cytoplasm, cytoskeleton.|
email@example.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
ARPC1A is one of seven subunits of the human Arp2/3 protein complex. This subunit is a member of the SOP2 family of proteins and is most similar to the protein ARPC1B. The similarity between these two proteins suggests that they both may function as p41 subunit of the human Arp2/3 complex that has been implicated in the control of actin polymerization in cells. It is possible that the p41 subunit is involved in assembling and maintaining the structure of the Arp2/3 complex. Multiple versions of the p41 subunit may adapt the functions of the complex to different cell types or developmental stages.
Laurila,E., Genes Chromosomes Cancer 48 (4), 330-339 (2009)
Machesky,L.M., Biochem. J. 328 (PT 1), 105-112 (1997)
If you have any additional inquiries please email technical services at firstname.lastname@example.org.